Last reviewed · How we verify

NCT05572541

Temporomandibular Joint Dysfunction in Patients With Traumatic Brain Injury

Status unknown Last updated 26 October 2022
What this trial tests

trial testing Fonseca questionnaire in Temporomandibular Dysfunction in 60 participants. Status unknown.

Timeline
5 November 2022
Primary endpoint
1 April 2023
1 April 2023

Quick facts

Lead sponsorKonya Beyhekim Training and Research Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date5 November 2022
Primary completion1 April 2023
Estimated completion1 April 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Konya Beyhekim Training and Research Hospital

Who can join

Adults 18 to 65, any sex, with Temporomandibular Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Trauma, neurological disorders and psychological problems, which are the etiological factors of temporomandibular joint dysfunction, can be seen in patients with traumatic brain injury. The aim of this study is to investigate temporomandibular joint dysfunction in patients with traumatic brain injury. Participants (traumatic brain injury patients and healthy volunteers) will be evaluated once for temporomandibular joint dysfunction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Konya Beyhekim Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05572541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing